Mathieu Wémeau
Impact in
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 28
- Myeloproliferative Neoplasms: Diagnosis and Treatment 15
- Chronic Lymphocytic Leukemia Research 10
- Hematology 22
- Acute Myeloid Leukemia Research 12
- Chronic Myeloid Leukemia Treatments 10
- Multiple Myeloma Research and Treatments 6
- Co-authors
- laurence ZITVOGEL (1 shared paper)Caroline Flament (1 shared paper)Nathalie Chaput (1 shared paper)Guido Kroemer (1 shared paper)Stéphane de Botton (1 shared paper)Theocharis Panaretakis (1 shared paper)Oliver Kepp (1 shared paper)Antoine Tesnière (1 shared paper)
- Journals
- Blood (7 papers)Haematologica (5 papers)European Journal Of Haematology (3 papers)Journal of Clinical Oncology (2 papers)Leukemia (2 papers)
- Partner nations
- FranceUnited StatesSweden
In The Last Decade
Mathieu Wémeau
38 papers receiving 592 citations
Peers
Comparison fields: 5 of 53
- Genetics 247
- Hematology 252
- Pathology and Forensic Medicine 99
- Immunology 120
- Oncology 115
Countries citing papers authored by Mathieu Wémeau
This map shows the geographic impact of Mathieu Wémeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Wémeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Wémeau more than expected).
Fields of papers citing papers by Mathieu Wémeau
This network shows the impact of papers produced by Mathieu Wémeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Wémeau. The network helps show where Mathieu Wémeau may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathieu Wémeau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 113 | |
| 2 | 2014 | 66 | |
| 3 | 2021 | 62 | |
| 4 | 2014 | 58 | |
| 5 | 2009 | 32 | |
| 6 | 2020 | 29 | |
| 7 | 2021 | 24 | |
| 8 | 2011 | 23 | |
| 9 | 2024 | 23 | |
| 10 | 2016 | 22 | |
| 11 | 2022 | 21 | |
| 12 | 2021 | 18 | |
| 13 | 2017 | 17 | |
| 14 | 2016 | 14 | |
| 15 | 2023 | 10 | |
| 16 | 2009 | 8 | |
| 17 | 2020 | 8 | |
| 18 | 2022 | 8 | |
| 19 | 2024 | 7 | |
| 20 | 2022 | 5 |
About Mathieu Wémeau
Mathieu Wémeau is a scholar working on Genetics, Hematology, Rheumatology, Immunology and Pathology and Forensic Medicine, having authored 43 papers that have together received 599 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers), Acute Myeloid Leukemia Research (12 papers), Chronic Myeloid Leukemia Treatments (10 papers), Chronic Lymphocytic Leukemia Research (10 papers), Multiple Myeloma Research and Treatments (6 papers), Kruppel-like factors research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Eosinophilic Disorders and Syndromes (4 papers). The work is most often cited by research in Genetics (247 citations), Hematology (252 citations), Pathology and Forensic Medicine (99 citations), Immunology (120 citations) and Oncology (115 citations). Mathieu Wémeau has collaborated with scholars based in France, United States and Sweden. Frequent co-authors include laurence ZITVOGEL, Caroline Flament, Nathalie Chaput, Guido Kroemer, Stéphane de Botton, Theocharis Panaretakis, Oliver Kepp, Antoine Tesnière, Xavier P. Leleu and Louis Terriou. Their work appears in journals such as Blood, Haematologica, European Journal Of Haematology, Journal of Clinical Oncology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.